DIA
DGX icon

Dean Investment Associates’s Quest Diagnostics DGX Stock Holding History

Dean Investment Associates’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.33M Buy
25,144
+498
+2% +$97.7K 0.7% 55
2026
Q1 		$4.83M Buy
24,646
+377
+2% +$73.2K 0.68% 54
2025
Q4 		$4.21M Buy
24,269
+622
+3% +$113K 0.6% 69
2025
Q3 		$4.51M Buy
23,647
+1,465
+7% +$260K 0.63% 54
2025
Q2 		$3.98M Buy
22,182
+1,070
+5% +$186K 0.59% 63
2025
Q1 		$3.57M Buy
21,112
+721
+4% +$118K 0.53% 75
2024
Q4 		$3.08M Buy
20,391
+882
+5% +$137K 0.44% 97
2024
Q3 		$3.03M Sell
19,509
-589
-3% -$88K 0.41% 112
2024
Q2 		$2.75M Buy
20,098
+3,394
+20% +$465K 0.39% 116
2024
Q1 		$2.22M Buy
16,704
+176
+1% +$22.8K 0.31% 136
2023
Q4 		$2.28M Buy
16,528
+4,892
+42% +$643K 0.33% 127
2023
Q3 		$1.42M Buy
11,636
+2,640
+29% +$352K 0.23% 171
2023
Q2 		$1.26M Sell
8,996
-248
-3% -$34.2K 0.21% 175
2023
Q1 		$1.31M Sell
9,244
-180
-2% -$25.8K 0.21% 168
2022
Q4 		$1.47M Sell
9,424
-157
-2% -$22.6K 0.25% 133
2022
Q3 		$1.18M Sell
9,581
-177
-2% -$23.3K 0.24% 162
2022
Q2 		$1.3M Sell
9,758
-51
-0.5% -$6.95K 0.25% 162
2022
Q1 		$1.34M Sell
9,809
-172
-2% -$24K 0.24% 167
2021
Q4 		$1.73M Sell
9,981
-648
-6% -$98.6K 0.3% 127
2021
Q3 		$1.54M Sell
10,629
-313
-3% -$45.8K 0.29% 140
2021
Q2 		$1.44M Buy
10,942
+238
+2% +$31.2K 0.27% 167
2021
Q1 		$1.37M Sell
10,704
-191
-2% -$23.5K 0.26% 182
2020
Q4 		$1.3M Buy
10,895
+729
+7% +$88.9K 0.27% 166
2020
Q3 		$1.16M Buy
10,166
+2,194
+28% +$259K 0.28% 149
2020
Q2 		$908K Buy
7,972
+35
+0.4% +$3.71K 0.22% 154
2020
Q1 		$637K Sell
7,937
-1,243
-14% -$129K 0.14% 192
2019
Q4 		$980K Buy
9,180
+19
+0.2% +$1.98K 0.15% 189
2019
Q3 		$981K Buy
9,161
+56
+0.6% +$5.75K 0.14% 167
2019
Q2 		$927K Buy
9,105
+66
+0.7% +$6.34K 0.13% 173
2019
Q1 		$813K Buy
9,039
+568
+7% +$49.2K 0.12% 186
2018
Q4 		$705K Sell
8,471
-121
-1% -$11.3K 0.11% 182
2018
Q3 		$927K Buy
8,592
+190
+2% +$20.8K 0.13% 162
2018
Q2 		$924K Buy
8,402
+1,246
+17% +$130K 0.14% 151
2018
Q1 		$718K Buy
+7,156
New +$733K 0.11% 184
2017
Q1 		– Sell
-6,831
Closed -$628K – 198
2016
Q4 		$628K Buy
6,831
+472
+7% +$40.7K 0.11% 166
2016
Q3 		$538K Buy
6,359
+58
+0.9% +$4.87K 0.1% 165
2016
Q2 		$513K Sell
6,301
-10
-0.2% -$761 0.1% 166
2016
Q1 		$451K Buy
6,311
+155
+3% +$10.4K 0.09% 189
2015
Q4 		$438K Hold
6,156
– – 0.1% 186
2015
Q3 		$378K Hold
6,156
– – 0.09% 203
2015
Q2 		$446K Hold
6,156
– – 0.1% 211
2015
Q1 		$473K Buy
+6,156
New +$441K 0.11% 190

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Dean Investment Associates's DGX Position: Q2 2026 in Review

Dean Investment Associates increased its Quest Diagnostics (DGX) stake by 2% in Q2 2026, buying an estimated $97.7K and bringing the position to 25,144 shares worth $5.33M. The position accounts for 0.7% of the portfolio, ranked #55.

Dean Investment Associates first reported a position in DGX in Q1 2015 and has held it in 42 quarters since. 1,099 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Dean Investment Associates held 25,144 shares of Quest Diagnostics worth $5.33M as of Q2 2026.
  • Dean Investment Associates bought 498 Quest Diagnostics shares in Q2 2026, an estimated $97.7K.
  • Quest Diagnostics made up 0.7% of Dean Investment Associates's portfolio in Q2 2026, its #55 holding.
  • Dean Investment Associates first reported a position in Quest Diagnostics in Q1 2015 and has held it in 42 quarters since.
  • 1,099 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Dean Investment Associates's 13F filing for Q2 2026, filed 14 Aug 2026.